These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 9613925

  • 1. Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium.
    Woessner RD, Wright PS, Loudy DE, Wallace CD, Montgomery LR, Nestok BR.
    Exp Mol Pathol; 1998; 65(1):37-52. PubMed ID: 9613925
    [Abstract] [Full Text] [Related]

  • 2. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate.
    Ravindranath N, Wion D, Brachet P, Djakiew D.
    J Androl; 2001; 22(3):432-43. PubMed ID: 11330643
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia.
    Jackson MW, Bentel JM, Tilley WD.
    J Urol; 1997 Jun; 157(6):2323-8. PubMed ID: 9146664
    [Abstract] [Full Text] [Related]

  • 4. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [Abstract] [Full Text] [Related]

  • 5. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
    Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S, Herlyn M.
    Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212
    [Abstract] [Full Text] [Related]

  • 6. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
    Hahn D, Simak R, Steiner GE, Handisurya A, Susani M, Marberger M.
    J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
    [Abstract] [Full Text] [Related]

  • 7. Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia.
    Nassis L, Frauman AG, Ohishi M, Zhuo J, Casley DJ, Johnston CI, Fabiani ME.
    J Pathol; 2001 Dec; 195(5):571-9. PubMed ID: 11745693
    [Abstract] [Full Text] [Related]

  • 8. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF.
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [Abstract] [Full Text] [Related]

  • 9. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
    Lee AH, Dublin EA, Bobrow LG, Poulsom R.
    J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838
    [Abstract] [Full Text] [Related]

  • 10. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor Flk-1 in benign, premalignant, and malignant prostate tissue.
    Köllermann J, Helpap B.
    Am J Clin Pathol; 2001 Jul; 116(1):115-21. PubMed ID: 11447740
    [Abstract] [Full Text] [Related]

  • 11. The expression of basic fibroblast growth factor and vascular endothelial growth factor in prostatic adenocarcinoma: correlation with neovascularization.
    Sugamoto T, Tanji N, Sato K, Fujita H, Nishio S, Sakanaka M, Yokoyama M.
    Anticancer Res; 2001 Jul; 21(1A):77-88. PubMed ID: 11299793
    [Abstract] [Full Text] [Related]

  • 12. Quantitation of vascular endothelial growth factor mRNA levels in human breast tumors and metastatic lymph nodes.
    Wright PS, Loudy DE, Cross-Doersen DE, Montgomery LR, Sprinkle-Cavallo J, Miller JA, Distler CM, Lower EE, Woessner RD.
    Exp Mol Pathol; 1997 Feb; 64(1):41-51. PubMed ID: 9203508
    [Abstract] [Full Text] [Related]

  • 13. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB, Nelson JB, Denmeade SR, Isaacs JT.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [Abstract] [Full Text] [Related]

  • 14. Angiogenically active vascular endothelial growth factor is over-expressed in malignant human and rat prostate carcinoma cells.
    Chen HJ, Treweeke AT, Ke YQ, West DC, Toh CH.
    Br J Cancer; 2000 May; 82(10):1694-701. PubMed ID: 10817506
    [Abstract] [Full Text] [Related]

  • 15. Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors.
    Sowter HM, Corps AN, Evans AL, Clark DE, Charnock-Jones DS, Smith SK.
    Lab Invest; 1997 Dec; 77(6):607-14. PubMed ID: 9426398
    [Abstract] [Full Text] [Related]

  • 16. A potential autocrine role for vascular endothelial growth factor in prostate cancer.
    Jackson MW, Roberts JS, Heckford SE, Ricciardelli C, Stahl J, Choong C, Horsfall DJ, Tilley WD.
    Cancer Res; 2002 Feb 01; 62(3):854-9. PubMed ID: 11830543
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
    Cardillo MR, Monti S, Di Silverio F, Gentile V, Sciarra F, Toscano V.
    Anticancer Res; 2003 Feb 01; 23(5A):3825-35. PubMed ID: 14666684
    [Abstract] [Full Text] [Related]

  • 18. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma.
    Shi Q, Le X, Abbruzzese JL, Peng Z, Qian CN, Tang H, Xiong Q, Wang B, Li XC, Xie K.
    Cancer Res; 2001 May 15; 61(10):4143-54. PubMed ID: 11358838
    [Abstract] [Full Text] [Related]

  • 19. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer.
    Ohta Y, Endo Y, Tanaka M, Shimizu J, Oda M, Hayashi Y, Watanabe Y, Sasaki T.
    Clin Cancer Res; 1996 Aug 15; 2(8):1411-6. PubMed ID: 9816315
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells.
    Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertsen PC, Laudone VP, Kreutzer DL.
    J Urol; 1997 Jun 15; 157(6):2329-33. PubMed ID: 9146665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.